Dataset Information

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.

ABSTRACT: The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.

SUBMITTER: Benson AB

PROVIDER: S-EPMC5557008 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.

Benson Al B AB D'Angelica Michael I MI Abbott Daniel E DE Abrams Thomas A TA Alberts Steven R SR Saenz Daniel Anaya DA Are Chandrakanth C Brown Daniel B DB Chang Daniel T DT Covey Anne M AM Hawkins William W Iyer Renuka R Jacob Rojymon R Karachristos Andrea A Kelley R Kate RK Kim Robin R Palta Manisha M Park James O JO Sahai Vaibhav V Schefter Tracey T Schmidt Carl C Sicklick Jason K JK Singh Gagandeep G Sohal Davendra D Stein Stacey S Tian G Gary GG Vauthey Jean-Nicolas JN Venook Alan P AP Zhu Andrew X AX Hoffmann Karin G KG Darlow Susan S

Journal of the National Comprehensive Cancer Network : JNCCN 20170501 5

The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for trea ...[more]

PMID: 28476736

Dataset Information

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.

Publications

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
| S-EPMC10191771 | biostudies-literature

NCCN Guidelines Insights: Colon Cancer, Version 2.2018.
| S-EPMC10184502 | biostudies-literature

NCCN Guidelines® Insights: Palliative Care, Version 2.2021.
| S-EPMC10196810 | biostudies-literature

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.
| S-EPMC10184498 | biostudies-literature

Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers.
| S-EPMC10598301 | biostudies-literature

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC10203817 | biostudies-literature

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC10191161 | biostudies-literature

Breast cancer, version 3.2013: featured updates to the NCCN guidelines.
| S-EPMC3991132 | biostudies-literature

Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC11807340 | biostudies-literature

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC10181270 | biostudies-literature